EX-10.20 2 blue-ex1020_259.htm EX-10.20Share Agreement • May 5th, 2020 • New York
Contract Type FiledMay 5th, 2020 Jurisdiction[***] INDICATES MATERIAL THAT HAS BEEN OMITTED AND FOR WHICH CONFIDENTIAL TREATMENT HAS BEEN REQUESTED. ALL SUCH OMITTED MATERIAL HAS BEEN FILED WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO RULE 24b-2 PROMULGATED UNDER THE SECURITIES ACT OF 1934, AS AMENDED
Amended and Restated Co-Development, Co-Promote and Profit Share Agreement by and between bluebird bio, Inc. and Celgene Corporation and Celgene European Investment Company LLC March 26, 2018Share Agreement • May 2nd, 2018 • Bluebird Bio, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledMay 2nd, 2018 Company Industry Jurisdiction